| Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Outline of Final Research Achievements |
As a result of LC-MS / MS analysis, syntenin-1 was identified as a molecule conjugated to the colon cancer stem cell marker Lgr5. The relationship between clinicopathological factors and prognosis of syntenin-1 expression was examined and functional analysis was performed. Overall survival rate was low expression group: high expression group = 97.8%: 63.8% (p = 0.001), 5 year low relapse survival rate was low expression group: high expression group = 92.4%: 61.7% (p = 0.001). The rate of recurrence was significantly higher and the survival rate was lower in the high expression group of syntenin-1. Silencing Syntenin-1 increased the sensitivity to L-OHP with significant difference (p <0.05).
|
